Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacterial Vaginosis
Treatment agents for bacterial vaginosis differ in microbiologic effects
November 18th, 2005
Two topical treatment agents for bacterial vaginosis differ in microbiologic effects on the vaginal microflora. In a recent study, researchers in the United States conducted a study "To compare the frequencies, concentrations, and antimicrobial susceptibilities of vaginal microbes isolated from women with bacterial vaginosis (BV) before and after therapy. One hundred nineteen nonpregnant women aged 18 to 45 with clinical and Gram stain evidence of BV were randomized to receive intravaginal clindamycin or metronidazole. Vaginal swabs were collected at baseline and 7 to 12 days, 35 to 45 days, and 70 to 90 days following therapy for quantitative vaginal culture." ...
Source: Drug Week (2005-11-18)
|
